^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

RD133

i
Other names: RD133, RD 133, RD-133
Associations
Company:
IASO BIO
Drug class:
CD19-targeted CAR-T immunotherapy, Mesothelin-targeted CAR-T immunotherapy
Related drugs:
Associations
over2years
Enrollment open
|
MSLN (Mesothelin)
|
MSLN positive
|
RD133
3years
An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors (clinicaltrials.gov)
P1, N=24, Recruiting, The First Affiliated Hospital with Nanjing Medical University
Clinical • New P1 trial
|
MSLN (Mesothelin)
|
MSLN positive
|
RD133
3years
Clinical • New P1 trial
|
MSLN (Mesothelin)
|
MSLN positive
|
RD133